Vida V. Herrera-Ruiz
Cp 44280
Guadalajara, JAL 44280, Mexico
Guadalajara, JAL 44280, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
miR-23a-3p as a Biomarker Associated with Prediabetes in People Living with HIV: An Integrative Analysis of Inflammatory, Metabolic, and Insulin Resistance Signatures.
Journal: International journal of molecular sciences
Published: May 21, 2026
The Impact of Gut Microbial Metabolomics on Type 2 Diabetes Development in People Living with HIV.
Journal: Metabolites
Published: August 19, 2025
Risk factors for drug-induced liver injury in people with HIV on anti-tuberculosis treatment.
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: May 19, 2025
Evaluation of CRP SNV rs2808630 and acute proinflammatory biomarkers in patients with CKD and PLHIV with CKD: a case-control study.
Journal: BMC nephrology
Published: November 25, 2024
Simplified Medication Adherence Questionnaire (SMAQ) for People Living With HIV in a National Hospital in Mexico: Instrument Validation Study.
Journal: Interactive journal of medical research
Published: April 15, 2024
TRAIL (DR5) receptor and the modulation of TRAIL pathway in PLWHIV: key mechanisms in the progression of HIV disease.
Journal: BMC molecular and cell biology
Published: March 12, 2024
Pilot study on the efficacy and safety of berberine in people with metabolic syndrome and human immunodeficiency virus infection.
Journal: International journal of STD & AIDS
Published: August 23, 2023
Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naïve HIV: A one-year prospective study.
Journal: PloS one
Published: September 26, 2022
Clinical features associated with neurosyphilis in people living with HIV and late latent syphilis.
Journal: International journal of STD & AIDS
Published: January 03, 2022
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Journal: The Lancet. Infectious diseases
Published: August 31, 2021
Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort.
Journal: BMC nephrology
Published: April 22, 2021
Last Updated: 09/26/2026